This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
AUTHORS : * Tinku Kumar Singh 1 , Satish Kumar 1 , Purna Tiwari 2 1 Indchemie health Specialities Pvt. Ltd 2 Alkem health science Ltd. tinku20190@gmail.com. . ABSTRACT : The World Health Organization (WHO) has declared the corona virus disease 2019 (COVID-19) a pandemic. In January 2020, a previously unknown new virus was identified subsequently named the 2019 novel corona virus, and samples obtained from cases and analysis of the virus’ genetics indicated that this was the cause of the outbrea
Fuld + Company is surveying how the work of Strategy, Competitive Intelligence and Market Insights functions is changing as companies respond to the global pandemic. Companies around the world are adjusting to the unprecedented operational and financial impact of the COVID-19 pandemic. With this short survey , Fuld + Company aims to better understand what has changed for specific strategy- and intelligence-focused functions and how they are supporting the response, re-positioning, and decision-m
Pharmacists practicing integrative medicine do not transition from the role of the pharmacist but rather expand it. Dr. Pam Tarlow and Dr. Swathi Varanasi highlight the importance of other modalities of health and even touch on the business implications of integrative medicine in the future! Dr. Pam Tarlow and Dr. Swathi Varanasi – Clinical, Integrative Pharmacists.
I’m extremely grateful for the many pharmacists who have stepped up and provided education on topics they are passionate about. I’ve touched on QT prolongation in the past, but Daniel Lieu, PharmD has taken it up a notch! He has provided some spot-on education below on QT Prolongation for Community Pharmacists that can be applied […].
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Insights on the impact of COVID-19 for pharma and biotech companies and considerations for a post-coronavirus new normal in life sciences and healthcare. It will also discuss the UK response to the emergency, clinical trials and how digital health has met the COVID-19 challenge for healthcare professionals, patients and industry.
Digoxin is one of those medications that has a lot of unique clinical quirks. Here are a few clinical pearls you must remember when using digoxin in CHF. When using digoxin in CHF (more specifically (HFrEF) you must remember to check electrolytes. Alterations in electrolytes may increase the risk of arrhythmias. When a patient has […]. The post Digoxin in CHF – What You Need to Know appeared first on Med Ed 101.
Amiodarone is a medication that you need to pay attention to. It has numerous clinical quirks that can cause serious harm if one is not aware of them. Here’s a list of the amiodarone boxed warnings as well as some other clinical practice pearls. Amiodarone Boxed Warning #1: Pro-Arrhythmic Amiodarone is classified as an antiarrhythmic […].
40
40
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Amiodarone is a medication that you need to pay attention to. It has numerous clinical quirks that can cause serious harm if one is not aware of them. Here’s a list of the amiodarone boxed warnings as well as some other clinical practice pearls. Amiodarone Boxed Warning #1: Pro-Arrhythmic Amiodarone is classified as an antiarrhythmic […].
I stumbled into this article a while ago regarding Nuedexta off-label fraud for behavioral issues involving dementia patients in long term care facilities. It makes me sad and frustrated. I’d like to make a couple of points. Nuedexta Off-Label Evidence in Dementia The evidence of Nuedexta being beneficial in this patient population for the off-label […].
AUTHORS : Gouranga Sundar Roy 1 *, Sangita Biswas 2 . Department of Pharmacy, Bengal School of Technology. (A College of Pharmacy), Sugandha, Delhi Road Near Chuchura, Hooghly - 712102, West Bengal, India. ABSTRACT: Scott Craniodigital syndrome is a situation that has best been found in families. The manifestations consist of uncommon head shape, boom and developmental delay, and mild webbing between the arms and toes.
Geriatrics can get very complicated very fast. Chronic conditions, polypharmacy, and drug interactions are a few of the many complications. Here are a few things that make me think twice in geriatric patients. Multiple Medication Changes As I reveiw a patient’s medication list, I review recent changes that have been made. The more changes that […].
I do get quite a few questions from time to time and try to answer as many emails as I can. Here were a few really good questions that I thought I would share with all of you. Can we use ciprofloxacin for pneumonia? Why isn’t ciprofloxacin a treatment in community-acquired pneumonia? Also, why is […]. The post Ciprofloxacin for Pneumonia?
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Loop diuretics are the mainstay in removing fluid off the body in patients with heart failure. They are very common in clinical practice. What should you think about when monitoring loop diuretics? Monitoring Loop Diuretics – Benefit? One of the challenges with polypharmacy in our geriatric patient population is to continually assess the benefit of […].
Mirabegron is a medication that can be used for overactive bladder. It is a medication that I am seeing used periodically in clinical practice. Here are a few mirabegron clinical pearls that I think are valuable to remember. The mechanism of action is critical to remember. It is a selective beta-3 agonist. You are likely […]. The post Mirabegron Clinical Pearls appeared first on Med Ed 101.
AUTHORS : 1 Charles Owusu-Aduomi Botchwey * , 2 Yaa Kusi-Ameyaa, 1 Isaac Adom-Konadu, 1 Ebenezer Dzinpa Effisah 1 University of Cape Coast 2 University of Professional Studies-Accra. chaboat08@yahoo.com *. ABSTRACT. Healthcare provision aims at ensuring that clients who visit a healthcare facility are provided with affordable and quality healthcare aimed at promoting the well-being of the people in the catchment areas of the healthcare facility.
Transitions of care are a big deal and something I care about deeply. I’ve seen so many mistakes in my practice as an MTM pharmacist, Assisted Living Consultant, LTC Consultant, and in community pharmacy. I recently watched some of Blair Thielemeir’s Elevate Pharmacy Summit and I was really inspired by the effort and energy this […].
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content